{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Acne&page=14", "query": { "condition": "Acne", "page": 14 }, "page_size": 10 }, "pagination": { "page": 14, "page_size": 10, "total_count": 489, "total_pages": 49, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Acne&page=15&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Acne&page=13&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-22T03:14:31.984Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01138735", "title": "Epiduo Pediatric Acne Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Acne" ], "interventions": [ { "name": "adapalene/benzoyl peroxide", "type": "DRUG" }, { "name": "Topical Gel Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Galderma R&D", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "9 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "9 Years to 11 Years" }, "enrollment_count": 285, "start_date": "2010-06", "completion_date": "2011-08", "has_results": true, "last_update_posted_date": "2021-02-18", "last_synced_at": "2026-10-22T03:14:31.984Z", "location_count": 20, "location_summary": "Birmingham, Alabama • San Diego, California • Santa Rosa, California + 17 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "San Diego", "state": "California" }, { "city": "Santa Rosa", "state": "California" }, { "city": "Miramar", "state": "Florida" }, { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01138735" }, { "nct_id": "NCT02608476", "title": "A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "CB-03-01 cream, 1%", "type": "DRUG" }, { "name": "Vehicle cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cassiopea SpA", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "9 Years", "maximum_age": null, "sex": "ALL", "summary": "9 Years and older" }, "enrollment_count": 732, "start_date": "2015-11-16", "completion_date": "2018-02-21", "has_results": true, "last_update_posted_date": "2020-11-20", "last_synced_at": "2026-10-22T03:14:31.984Z", "location_count": 12, "location_summary": "Scottsdale, Arizona • Fort Smith, Arkansas • Sacramento, California + 7 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Fort Smith", "state": "Arkansas" }, { "city": "Sacramento", "state": "California" }, { "city": "Pinellas Park", "state": "Florida" }, { "city": "Arlington Heights", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02608476" }, { "nct_id": "NCT00031096", "title": "Comparison of Efficacy and Safety of Azelaic Acid 15% Gel With Its Vehicle in Subjects With Mild to Moderate Acne", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "Azelaic Acid Gel 15% (Finacea, BAY39-6251)", "type": "DRUG" }, { "name": "Vehicle gel (SH H 655 PBA)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "LEO Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 879, "start_date": "2002-01", "completion_date": "2002-07", "has_results": false, "last_update_posted_date": "2023-06-09", "last_synced_at": "2026-10-22T03:14:31.984Z", "location_count": 16, "location_summary": "Mobile, Alabama • Boulder, Colorado • Newnan, Georgia + 13 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Boulder", "state": "Colorado" }, { "city": "Newnan", "state": "Georgia" }, { "city": "Shawnee Mission", "state": "Kansas" }, { "city": "Wichita", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00031096" }, { "nct_id": "NCT02798120", "title": "P3 Long Term Safety Study of Once Daily SB204 in Acne", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "SB204 4%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novan, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "9 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "9 Years to 99 Years" }, "enrollment_count": 601, "start_date": "2016-05-12", "completion_date": "2017-04-27", "has_results": true, "last_update_posted_date": "2023-05-12", "last_synced_at": "2026-10-22T03:14:31.984Z", "location_count": 69, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 59 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Cerritos", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02798120" }, { "nct_id": "NCT03073486", "title": "A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "Olumacostat Glasaretil Gel, 5.0%", "type": "DRUG" }, { "name": "Olumacostat Glasaretil Gel, Vehicle", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Dermira, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "9 Years", "maximum_age": null, "sex": "ALL", "summary": "9 Years and older" }, "enrollment_count": 744, "start_date": "2017-02-06", "completion_date": "2017-12-21", "has_results": true, "last_update_posted_date": "2021-07-20", "last_synced_at": "2026-10-22T03:14:31.984Z", "location_count": 36, "location_summary": "Guntersville, Alabama • Glendale, Arizona • Bryant, Arkansas + 32 more", "locations": [ { "city": "Guntersville", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Bryant", "state": "Arkansas" }, { "city": "Rogers", "state": "Arkansas" }, { "city": "Fremont", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03073486" }, { "nct_id": "NCT02709096", "title": "BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "BPX-01, 1% Topical Gel", "type": "DRUG" }, { "name": "BPX-01 Vehicle Gel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "BioPharmX, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 33, "start_date": "2016-04", "completion_date": "2016-06", "has_results": true, "last_update_posted_date": "2017-09-14", "last_synced_at": "2026-10-22T03:14:31.984Z", "location_count": 1, "location_summary": "Broomall, Pennsylvania", "locations": [ { "city": "Broomall", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02709096" }, { "nct_id": "NCT04031469", "title": "A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease", "overall_status": "SUSPENDED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Gut Microbiome", "Gastrointestinal Microbiome", "Autism", "Autism Spectrum Disorder", "Autism Spectrum Disorder High-Functioning", "Alzheimer Disease", "Alzheimer Dementia (AD)", "Alzheimer Dementia", "Alzheimer Disease (AD)", "Crohn", "Crohn Colitis", "Crohn Disease (CD)", "Crohn Disease Colon", "Myalgic Encephalomyelitis", "ME/CFS", "Myalgic Encephalomyelitis (ME)", "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome", "Psoriasis", "Psoriasis Annularis", "Psoriasis Chronic", "Chronic Urinary Tract Infection", "Ulcerative Colitis (Disorder)", "Ulcerative Colitis (UC)", "Ulcerative Colitis Acute", "Ulcerative Colitis Chronic", "Multiple Sclerosis", "Multiple Sclerosis (MS) - Relapsing-remitting", "Multiple Sclerosis (MS) Primary Progressive", "Constipation Chronic Idiopathic", "Constipation", "Celiac", "Celiac Disease", "Celiac Sprue", "Lyme Arthritis", "Lyme Borreliosis, Nervous System", "Lyme Disease, Chronic", "Cholesterol", "Cholesterol Level, High", "Cancer", "Colon Cancer", "Amyotrophic Lateral Sclerosis (ALS)", "Amyotrophic Lateral Sclerosis", "Rheumatoid Arthritis (RA)", "Rheumatoid Arthritis - Rheumatism", "Chronic Fatigue Syndrome (CFS)", "PARKINSON DISEASE (Disorder)", "Parkinson Disease", "Parkinson Disease (PD)", "Depression", "Major Depressive Disorder (MDD)", "Depression Disorder", "Depression in Adults", "Anxiety", "Anxiety Disorder Generalized", "Obsessive Compulsive Disorder (OCD)", "Obsessive Compulsive Disorder OCD", "Obsessive - Compulsive Disorder", "Bipolar", "Bipolar 1 Disorder", "Bipolar Disorder (BD)", "Bipolar Disorder I and II", "Bipolar and Related Disorders", "Migraine", "Migraine Disorder", "Diabetes (DM)", "Diabetes", "Lupus", "Lupus Erythematosus", "Epidermolysis Bullosa (EB)", "Mesothelioma", "Mesothelioma Malignant", "IBS (Irritable Bowel Syndrome)", "Irritable Bowel", "IBS - Irritable Bowel Syndrome", "Irritable Bowel Syndrome (IBS)", "Eczema", "Eczema Atopic Dermatitis", "Acne", "Myasthaenia Gravis", "Gout" ], "interventions": [ { "name": "There is no intervention in this study", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "ProgenaBiome", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 1000, "start_date": "2019-07-11", "completion_date": "2030-12-10", "has_results": false, "last_update_posted_date": "2026-09-21", "last_synced_at": "2026-10-22T03:14:31.984Z", "location_count": 1, "location_summary": "Ventura, California", "locations": [ { "city": "Ventura", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04031469" }, { "nct_id": "NCT05620836", "title": "A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hidradenitis Suppurativa (HS)" ], "interventions": [ { "name": "Povorcitinib", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Incyte Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 619, "start_date": "2023-02-22", "completion_date": "2025-11-21", "has_results": false, "last_update_posted_date": "2026-01-09", "last_synced_at": "2026-10-22T03:14:31.984Z", "location_count": 38, "location_summary": "Scottsdale, Arizona • Arkansas City, Arkansas • Fayetteville, Arkansas + 33 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Arkansas City", "state": "Arkansas" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05620836" }, { "nct_id": "NCT03433378", "title": "To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne Vulgaris", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "Tretinoin cream, 0.05%", "type": "DRUG" }, { "name": "RETIN-A® (tretinoin) cream, 0.05%", "type": "DRUG" }, { "name": "Vehicle of the test product", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sun Pharmaceutical Industries, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "12 Years to 40 Years" }, "enrollment_count": 700, "start_date": "2017-08-04", "completion_date": "2018-01-26", "has_results": false, "last_update_posted_date": "2018-05-18", "last_synced_at": "2026-10-22T03:14:31.984Z", "location_count": 1, "location_summary": "Charlotte, North Carolina", "locations": [ { "city": "Charlotte", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03433378" }, { "nct_id": "NCT01701024", "title": "Clinical Study to Test the Efficacy and Safety of ACYC to Treat Moderate to Severe Acne", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acne" ], "interventions": [ { "name": "ACYC", "type": "DRUG" }, { "name": "ACYC vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bausch Health Americas, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "12 Years to 40 Years" }, "enrollment_count": 498, "start_date": "2012-10", "completion_date": "2013-07", "has_results": true, "last_update_posted_date": "2018-06-04", "last_synced_at": "2026-10-22T03:14:31.984Z", "location_count": 24, "location_summary": "Mobile, Alabama • Los Angeles, California • San Diego, California + 21 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Aventura", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01701024" } ] }